Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-25

Clinical Trial Update: Introduction of EndoSign ® in Management of Barrett's Oesophagus - a Swedish Feasibility Study [NA]

View source ↗

Summary

A completed Swedish feasibility study assessing the use of EndoSign for management of Barrett Esophagus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EndoSign

Snippet

Sponsor: Vastra Gotaland Region | Conditions: Barrett Esophagus | NA | Status: COMPLETED